Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 Dec;58(4):497–504. doi: 10.1111/j.1476-5381.1976.tb08616.x

Extra-vesicular binding of noradrenaline and guanethidine in the adrenergic neurones of the rat heart: a proposed site of action of adrenergic neurone blocking agents.

A Giachetti, R A Hollenbeck
PMCID: PMC1667487  PMID: 1000128

Abstract

1 The binding and efflux characteristics of [14C]-guanethidine and [3H]-noradrenaline were studied in heart slices from rats which were pretreated with reserpine and nialamide. 2 Binding of both compounds occurred at extra-vesicular sites within the adrenergic neurone. After a brief period of rapid washout, the efflux of [14C]-guanethidine and [3H]-noradrenaline proceeded at a steady rate. The efflux of both compounds appeared to occur from a single intraneuronal compartment. 3 (+)-Amphetamine accelerated the efflux of [14C]-noradrenaline; this effect was inhibited by desipramine. 4 Unlabelled guanethidine and amantadine also increased the efflux of labelled compounds. Cocaine in high concentrations increased slightly the efflux of [14C]-guanethidine but not that of [3H]-noradrenaline. 5 Heart slices labelled with [3H]-noradrenaline became refractory to successive exposures to releasing agents although an appreciable amount of labelled compound was still present in in these slices. 6 It is suggested that [14C]-guanethidine and [3H]-noradrenaline are bound at a common extravesicular site within the adrenergic neurone. Binding of guanethidine to the extra-vesicular site may be relevant to its pharmacological action, i.e., the blockade of adrenergic transmission.

Full text

PDF
497

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABERCROMBIE G. F., DAVIES B. N. The action of guanethidine with particular reference to the sympathetic nervous system. Br J Pharmacol Chemother. 1963 Feb;20:171–177. doi: 10.1111/j.1476-5381.1963.tb01307.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ANTON A. H., SAYRE D. F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962 Dec;138:360–375. [PubMed] [Google Scholar]
  3. Abbs E. T., Dodd M. G. The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives. Br J Pharmacol. 1974 Jun;51(2):237–247. doi: 10.1111/j.1476-5381.1974.tb09653.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Abbs E. T., Pycock C. J. The effects of bretylium on the subcellular distribution of noradrenaline and on adrenergic nerve function in rat heart. Br J Pharmacol. 1973 Sep;49(1):11–22. doi: 10.1111/j.1476-5381.1973.tb08263.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Abbs E. T., Robertson M. I. Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium. Br J Pharmacol. 1970 Apr;38(4):776–791. doi: 10.1111/j.1476-5381.1970.tb09887.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. COUPLAND R. E., EXLEY K. A. Effects of choline 2:6-xylyl ether bromide upon the suprarenal medulla of the rat. Br J Pharmacol Chemother. 1957 Sep;12(3):306–311. doi: 10.1111/j.1476-5381.1957.tb00139.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DAY M. D. Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine. Br J Pharmacol Chemother. 1962 Apr;18:421–439. doi: 10.1111/j.1476-5381.1962.tb01421.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DAY M. D., RAND M. J. Evidence for a competitive antagonism of guanethidine by dexamphetamine. Br J Pharmacol Chemother. 1963 Feb;20:17–28. doi: 10.1111/j.1476-5381.1963.tb01293.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DENGLER H. J., SPIEGEL H. E., TITUS E. O. Effects of drugs on uptake of isotopic norepinephrine by cat tissues. Nature. 1961 Aug 19;191:816–817. doi: 10.1038/191816a0. [DOI] [PubMed] [Google Scholar]
  10. Enna S. J., Shore P. A. On the nature of the adrenergic neuron extragranular amine binding site. J Neural Transm. 1974;35(2):125–135. doi: 10.1007/BF01250740. [DOI] [PubMed] [Google Scholar]
  11. Farnebo L. O. Effect of d-amphetamine on spontaneous and stimulation-induced release of catecholamines. Acta Physiol Scand Suppl. 1971;371:45–52. doi: 10.1111/j.1748-1716.1971.tb05214.x. [DOI] [PubMed] [Google Scholar]
  12. Farnebo L. O., Fuxe K., Goldstein M., Hamberger B., Ungerstedt U. Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease. Eur J Pharmacol. 1971 Sep;16(1):27–38. doi: 10.1016/0014-2999(71)90053-7. [DOI] [PubMed] [Google Scholar]
  13. Follenfant M. J., Robson R. D. The antagonism of adrenergic neurone blockade by amphetamine and dexamphetamine in the rat and guinea-pig. Br J Pharmacol. 1970 Apr;38(4):792–801. doi: 10.1111/j.1476-5381.1970.tb09888.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gerkens J. F., McCulloch M. W. Mechanism of the antagonism between guanethidine and dexamphetamine. Br J Pharmacol. 1969 Mar;35(3):563–572. doi: 10.1111/j.1476-5381.1969.tb08297.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Haeusler G., Haefely W., Huerlimann A. On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn Schmiedebergs Arch Pharmakol. 1969;265(3):260–277. doi: 10.1007/BF01002340. [DOI] [PubMed] [Google Scholar]
  16. KOELLE G. B. A new general concept of the neurohumoral functions of acetylcholine and acetylcholinesterase. J Pharm Pharmacol. 1962 Feb;14:65–90. doi: 10.1111/j.2042-7158.1962.tb11057.x. [DOI] [PubMed] [Google Scholar]
  17. Kirpekar S. M., Furchgott R. F. Interaction of tyramine and guanethidine in the spleen of the cat. J Pharmacol Exp Ther. 1972 Jan;180(1):38–46. [PubMed] [Google Scholar]
  18. Kirpekar S. M., Wakade A. R., Dixon W., Prat J. C. Effect of cocaine, phenoxybenzamine and calcium on the inhibition of norepinephrine output from the cat spleen by guanthidine. J Pharmacol Exp Ther. 1969 Feb;165(2):166–175. [PubMed] [Google Scholar]
  19. Lundborg P., Waldeck B. On the mechanism of amphetamine induced release of reserpine-resistant 3 H-noradrenaline and 3 H- -methylnoradrenaline. Acta Pharmacol Toxicol (Copenh) 1971;30(5):339–347. doi: 10.1111/j.1600-0773.1972.tb00665.x. [DOI] [PubMed] [Google Scholar]
  20. Malmfors T. Histochemical studies on the effect of nerve impulses on exogenous catecholamines taken up into the adrenergic nerves of reserpine-pretreated animals. Pharmacology. 1969;2(4):193–208. doi: 10.1159/000136019. [DOI] [PubMed] [Google Scholar]
  21. Medina M. A., Giachetti A., Shore P. A. On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin. Biochem Pharmacol. 1969 Apr;18(4):891–901. doi: 10.1016/0006-2952(69)90060-4. [DOI] [PubMed] [Google Scholar]
  22. Mitchell J. R., Oates J. A. Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs. J Pharmacol Exp Ther. 1970 Mar;172(1):100–107. [PubMed] [Google Scholar]
  23. ROSS S. B., RENYI A. L. BLOCKING ACTION OF SYMPATHOMIMETIC AMINES ON THE UPTAKE OF TRITIATED NORADRENALINE BY MOUSE CEREBRAL CORTEX TISSUES IN VITRO. Acta Pharmacol Toxicol (Copenh) 1964;21:226–239. doi: 10.1111/j.1600-0773.1964.tb01787.x. [DOI] [PubMed] [Google Scholar]
  24. Ross S. B., Gosztonyi T. On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves. Naunyn Schmiedebergs Arch Pharmacol. 1975;288(2-3):283–293. doi: 10.1007/BF00500533. [DOI] [PubMed] [Google Scholar]
  25. Shand D. G., Morgan D. H., Oates J. A. The release of guanethidine and bethanidine by splenic nerve stimulation: a quantitative evaluation showing dissociation from adrenergic blockade. J Pharmacol Exp Ther. 1973 Jan;184(1):73–80. [PubMed] [Google Scholar]
  26. Thoenen H., Hürlimann A., Haefely W. Mechanism of amphetamine accumulation in the isolated perfused heart of the rat. J Pharm Pharmacol. 1968 Jan;20(1):1–11. doi: 10.1111/j.2042-7158.1968.tb09611.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES